文献速递颈动脉与弓上血管

颈动脉血运重建术式的性别差异表现

Performance of Carotid Revascularization Procedures as Modified by Sex.
PubMed 文献 · Ann Vasc Surg · 2021-11-06

基于SVS VQI CEA与支架登记及TCAR监测项目数据的回顾性分析,纳入75538例患者(女性28960例,占38.3%)。比较TCAR、TFCAS与CEA按性别分层的院内及1年结局,发现TCAR在男女中表现与CEA相似,TFCAS不良结局较多。

要点

  • 女性TFCAS较CEA的卒中/死亡OR为2.85(95%CI 2.21-3.67,P<0.001)。
  • 男性TFCAS较CEA的死亡OR为3.45(95%CI 2.53-4.71,P<0.001)。
  • TCAR在男女中1年卒中/死亡风险与CEA相当。

核心结论

  • TCAR在男女两性中表现与CEA相似,无论症状状态如何。
  • 在有症状和无症状的男女患者中,CEA或TCAR治疗的卒中/死亡及卒中/死亡/心肌梗死发生率相似。
  • TCAR的1年结局在男女中均与CEA相当。
  • 作者认为,当手术风险禁止CEA时,TCAR似乎是CEA的安全替代方案,尤其在女性中,而TFCAS与大量不良结局相关。

研究设计与样本

  • 回顾性分析SVS VQI CEA与支架登记及TCAR监测项目数据。
  • 共纳入75538例患者,女性28960例(38.3%),男性46578例(61.7%)。
  • 按性别比较TCAR、TFCAS与CEA的结局。

主要发现

  • 女性TFCAS较CEA的卒中/死亡OR为2.85(95%CI 2.21-3.67,P<0.001),卒中/死亡/心肌梗死OR为2.23(95%CI 1.75-2.83,P<0.001)。
  • 女性TFCAS较CEA的短暂性脑缺血发作OR为2.01(95%CI 1.19-3.42,P=0.010),TCAR较CEA的短暂性脑缺血发作OR为1.91(95%CI 1.09-3.35,P=0.023)。
  • 女性TFCAS较CEA的卒中/短暂性脑缺血发作OR为1.96(95%CI 1.45-2.65,P<0.001)。
  • 男性TFCAS较CEA的卒中/死亡OR为1.74(95%CI 1.39-2.16,P<0.001),卒中/死亡/心肌梗死OR为1.44(95%CI 1.19-1.75,P<0.001),死亡OR为3.45(95%CI 2.53-4.71,P<0.001)。
  • 男性TCAR较CEA的心肌梗死OR为0.52(95%CI 0.34-0.80,P=0.003);校正协变量后TFCAS与CEA的院内卒中风险相当。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current recommendations on carotid revascularization postulate that women have both increased perioperative risks, such as stroke and death, as well as reduced benefit from intervention. These recommendations do not include data on transcarotid artery revascularization (TCAR). This study strives to compare safety and benefits of TCAR, TFCAS (Transfemoral Carotid Artery Stenting), and CEA (Carotid Endarterectomy) with regard to patient sex. METHODS: We performed retrospective analysis of the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) CEA and stenting registries, as well as TCAR Surveillance Project data. We compared outcomes after TCAR, TFCAS, and CEA based on sex. The primary outcome was the rate of in-hospital stroke or death. Secondary outcomes included in-hospital stroke, death, transient ischemic attack (TIA), myocardial infarction (MI), stroke/death/MI, stroke/TIA, and recurrent ipsilateral stroke and/or death at 1-year of follow-up. RESULTS: A total of 75,538 patients were included, of which 28,960 (38.3%) were female and 46,578 (61.7%) were male. TFCAS females had more than 2 times higher odds of stroke/death (OR:2.85, 95%CI: 2.21-3.67, P < 0.001) and stroke/death/MI (OR:2.23, 95%CI:1.75-2.83, P < 0.001) when compared to CEA females. Odds of TIA were also higher in both TFCAS females (OR:2.01, 95%CI:1.19-3.42, P = 0.010) and TCAR females (OR:1.91, 95%CI:1.09-3.35, P = .023) when compared to CEA females. However, only TFCAS females experienced increased odds of stroke/TIA (OR:1.96, 95%CI:1.45-2.65, P < 0.001) when compared to CEA females. TFCAS males had almost twice the odds of stroke/death (OR:1.74, 95%CI:1.39-2.16, P < 0.001) and 44% higher odds of stroke/death/MI (OR:1.44, 95%CI:1.19-1.75, P < 0.001), and more than 3-times increased odds of death (OR:3.45, 95%CI:2.53-4.71, P < 0.001) when compared to CEA males. Odds of in-hospital stroke were comparable between TFCAS and CEA after adjusting for covariates. TCAR males have half the odds of MI when compared to CEA males (OR:0.52, 95%CI:0.34-0.80, P = 0.003). At 1-year TCAR had comparable risk of stroke/death while TFCAS had increased risk of stroke/death when compared to CEA among both males and females. CONCLUSION: TCAR performed similarly to CEA in both sexes regardless of symptomatic status. Stroke/death and stroke/death/MI rates were similar in symptomatic and asymptomatic males and females treated by CEA or TCAR. The 1-year outcomes of TCAR were also comparable to CEA in both sexes. It seems that TCAR may be a safe alternative to CEA particularly in women when surgical risk prohibits CEA and while TFCAS is associated with substantial adverse outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cui CL, Zarrintan S, Marmor RA, et al. Performance of Carotid Revascularization Procedures as Modified by Sex. Ann Vasc Surg. 2021. PMID: 34752853. doi:10.1016/j.avsg.2021.08.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。